Reaction

Atypical Mycobacterial Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,375 reports · 59 co-occurring drugs

As of the last recalculation, Atypical Mycobacterial Infection appears in 1,375 FAERS reports alongside 59 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPIN (PRR 59.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Rifampin	55	59.4	59.6
Rifampicin	30	45.9	46.0
Clarithromycin	92	43.4	43.5
Amikacin	45	41.2	41.4
Moxifloxacin	31	34.1	34.1
Azithromycin	66	26.0	26.1
Azithromycin Monohydrate	67	25.5	25.6
Moxifloxacin Hydrochloride	33	25.2	25.3
Lopinavir And Ritonavir	20	22.7	22.7
Azithromycin Dihydrate	72	19.6	19.6
Prednisolone	200	19.5	19.5
Prednisolone Oral	200	19.5	19.5
Prednisolone Oral Solution	200	19.5	19.5
Methylprednisolone Acetate	10	19.0	19.1
Dolutegravir Sodium	11	18.6	18.6
Basiliximab	14	18.2	18.2
Efavirenz	13	17.8	17.8
Itraconazole	13	17.0	17.0
Tacrolimus Ointment 0.1%	127	16.9	16.9
Tacrolimus Extended-Release Capsules	127	16.9	16.9
Mycophenolate Mofetil Hydrochloride	136	16.7	16.7
Mycophenolate Mofetil	135	16.6	16.6
Tacrolimus	153	16.5	16.5
Tenofovir Disoproxil Fumarate Tablets	9	15.9	15.9
Isoniazid	16	15.1	15.1
Linezolid	28	14.5	14.5
Micafungin Sodium	8	14.4	14.4
Baricitinib	9	14.2	14.2
Lamivudine Oral	23	14.0	14.0
Valganciclovir	17	13.8	13.8
Valganciclovir Hydrochloride	17	13.8	13.8
Lamivudine	27	13.5	13.5
Emtricitabine And Tenofovir Alafenamide	10	13.4	13.5
Ritonavir	24	12.6	12.6
Abacavir Sulfate	8	12.5	12.5
Raltegravir	13	12.0	12.0
Pyrazinamide	7	11.3	11.3
Mycophenilic Acid	15	11.1	11.1
Adalimumab-Fkjp	33	11.0	11.0
Adalimumab-Aaty	33	10.8	10.8
Valganciclovir Hydrochloride Powder,	8	10.0	10.0
Atovaquone	5	9.4	9.4
Tofacitinib Citrate	8	9.3	9.3
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	11	9.3	9.3
Zidovudine	8	9.1	9.1
Voriconazole	18	9.1	9.1
Sirolimus	8	9.0	9.0
Emtricitabine And Tenofovir Disoproxil Fumarate	26	8.8	8.8
Elexacaftor, Tezacaftor, And Ivacaftor	7	8.5	8.5
Atazanavir	8	8.5	8.5
Voriconazole Injection	12	8.4	8.4
Thiotepa	4	6.4	6.4
Abatacept	55	6.2	6.2
Golimumab	34	6.1	6.1
Canakinumab	4	5.6	5.6
Tenofovir Disoproxil Fumarate	11	5.1	5.1
Bendamustine Hydrochloride	4	5.1	5.1
Obinutuzumab	5	4.6	4.6
Botulinum Toxin Type A	3	3.7	3.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.